SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Brooks Laboratories informs about closure of trading window

05 Aug 2016 Evaluate

Brooks Laboratories has informed that a Meeting of Board of Directors of the Company is scheduled to be held on August 12, 2016, to consider and approve Unaudited Financial Results of the Company, for the 1st quarter ended June 30, 2016. Pursuant to this, the Company has decided that the close period (i.e. closure of trading window) for Insiders covered under ‘Code of Conduct for Prohibition of Insider Trading’ of Brooks Laboratories would commence from August 05, 2016 and will end 48 hours after the results are made public on August 12, 2016.

The above information is a part of company’s filings submitted to BSE.

Brooks Laboratories Share Price

64.77 3.08 (4.99%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×